References
- Charman SA Charman WN. (2003). Oral modified-release delivery systems. In: Rathbone MJ, Hadgraft J, Roberts MS, editor. Modified-Release Drug Delivery Technology. Marcel Dekker, 1–10.
- Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18:113–120.
- Müller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations In therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev, 47:3–19.
- Rabinow BE. (2004). Nanosuspensions In drug delivery. Nat Rev Drug Discov, 3:785–796.
- Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 59:631–644.
- Merisko-Liversidge E, Liversidge GG. (2011). Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev, 63:427–440.
- Vergote GJ, Vervaet C, Van Driessche I, Hoste S, De Smedt S, Demeester J et al. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm, 219:81–87.
- Lee J. (2003). Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci, 92:2057–2068.
- Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm, 299:167–177.
- Chaubal MV, Popescu C. (2008). Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res, 25:2302–2308.
- Lee J, Cheng Y. (2006). Critical freezing rate In freeze drying nanocrystal dispersions. J Control Release, 111:185–192.
- Ho H, Lee J. (2012). Redispersible drug nanoparticles prepared without dispersant by electro-spray drying. Drug Dev Ind Pharm, 38:744–751.
- Möschwitzer J, Müller, RH, (eds). (2004). From the drug nanocrystal to the final mucoadhesive oral dosage form. Proceedings of APV Int. Meeting on Pharm., Biopharm. and Pharm. Technology, Nuremberg ,2004.
- Pinto JF, Müller RH. (1999). Pellets as carriers of solid lipid nanoparticles (SLN™) for oral administration of drugs. Die Pharmazie, 54:506–509.
- Möschwitzer J, Müller RH. (2006). Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. Eur J Pharm Biopharm, 62:282–287.
- Kayaert P, Anné M, Van den Mooter G. (2011). Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads. J Pharm Pharmacol, 63:1446–1453.
- Wang P, Luo Q, Miao Y, Ying L, He H, Cai C, et al. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering. Drug Dev Ind Pharm, 1–10. DOI: 10.3109/03639045.2011.650647 (published online first).
- EMA. (2004). Scientific discussion on Emend. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion_-_Variation/human/000527/WC500026538.pdf.
- Basa S, Muniyappan T, Karatgi P, Prabhu R, Pillai R. (2008). Production and In vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm, 34:1209–1218.
- Chen X, Matteucci ME, Lo CY, Johnston KP, Williams RO 3rd. (2009). Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm, 35:283–296.
- Tromm A, Möllmann H, Barth J, Hochhaus G, Krieg M, Bigalke C et al. (2001). Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration In healthy subjects and patients. J ClIn Pharmacol, 41:536–541.
- Gardner RC. (1976). Pharmacotherapy of inflammatory bowel disease. Am J Hosp Pharm, 33:831–838.
- Rasenack N, Hartenhauer H, Müller BW. (2003). Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm, 254:137–145.
- Krause KP, Müller RH. (2001). Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation. Int J Pharm, 214:21–24.